Variant report

Variant	nsv912471
Chromosome Location	chr19:55873726-55878521
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:57)
CpG islands
(count:610)
Chromatin interactive
region (count:18)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:6)

(count:57 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BCL3	chr19:55874913-55876452	A549	lung:	n/a	n/a
2	BCL3	chr19:55875139-55875872	A549	lung:	n/a	n/a
3	CEBPB	chr19:55874700-55874900	HepG2	liver:	n/a	n/a
4	CEBPB	chr19:55874713-55874924	A549	lung:	n/a	n/a
5	CEBPB	chr19:55874706-55874874	K562	blood:	n/a	n/a
6	CEBPB	chr19:55876101-55876394	IMR90	lung:	n/a	n/a
7	CHD2	chr19:55877713-55877739	H1-hESC	embryonic stem cell:	n/a	n/a
8	CTCF	chr19:55876088-55876144	GM13976	blood:	n/a	n/a
9	EGR1	chr19:55877289-55877686	K562	blood:	n/a	n/a
10	EGR1	chr19:55877313-55877630	K562	blood:	n/a	n/a
11	ELF1	chr19:55875165-55875563	A549	lung:	n/a	chr19:55875254-55875266
12	FOXA2	chr19:55874594-55874973	A549	lung:	n/a	n/a
13	GATA3	chr19:55874959-55876287	A549	lung:	n/a	n/a
14	JUND	chr19:55874813-55875888	A549	lung:	n/a	n/a
15	JUND	chr19:55875062-55875915	A549	lung:	n/a	n/a
16	MYC	chr19:55873923-55874062	MCF-7	breast:	n/a	n/a
17	PBX3	chr19:55874794-55875764	A549	lung:	n/a	n/a
18	PBX3	chr19:55874792-55876466	A549	lung:	n/a	n/a
19	POLR2A	chr19:55876682-55876900	A549	lung:	n/a	n/a
20	POLR2A	chr19:55878171-55878408	MCF10A-Er-Src	breast:	n/a	n/a
21	POLR2A	chr19:55876392-55876621	Hela-S3	cervix:	n/a	n/a
22	POLR2A	chr19:55876123-55876125	MCF10A-Er-Src	breast:	n/a	n/a
23	POLR2A	chr19:55876990-55877124	Hela-S3	cervix:	n/a	n/a
24	POLR2A	chr19:55877320-55877494	A549	lung:	n/a	n/a
25	POLR2A	chr19:55875393-55875601	A549	lung:	n/a	n/a
26	POLR2A	chr19:55877576-55877672	A549	lung:	n/a	n/a
27	POLR2A	chr19:55874036-55876438	A549	lung:	n/a	n/a
28	POLR2A	chr19:55875420-55875437	ProgFib	skin:	n/a	n/a
29	POLR2A	chr19:55876833-55876834	MCF-7	breast:	n/a	n/a
30	POLR2A	chr19:55876225-55876342	ProgFib	skin:	n/a	n/a
31	POLR2A	chr19:55877357-55877451	A549	lung:	n/a	n/a
32	POLR2A	chr19:55875469-55875595	A549	lung:	n/a	n/a
33	POLR2A	chr19:55875151-55875317	A549	lung:	n/a	n/a
34	POLR2A	chr19:55874898-55875023	A549	lung:	n/a	n/a
35	POLR2A	chr19:55876730-55876894	A549	lung:	n/a	n/a
36	POLR2A	chr19:55876841-55876869	MCF-7	breast:	n/a	n/a
37	POLR2A	chr19:55875583-55875733	MCF10A-Er-Src	breast:	n/a	n/a
38	POLR2A	chr19:55875170-55875333	A549	lung:	n/a	n/a
39	POLR2A	chr19:55873343-55882901	IMR90	lung:	n/a	n/a
40	POLR2A	chr19:55874897-55875069	A549	lung:	n/a	n/a
41	POLR2A	chr19:55875413-55875724	A549	lung:	n/a	n/a
42	POLR2A	chr19:55876050-55876299	A549	lung:	n/a	n/a
43	POLR2A	chr19:55876871-55877128	MCF10A-Er-Src	breast:	n/a	n/a
44	POLR2A	chr19:55876680-55877854	A549	lung:	n/a	n/a
45	REST	chr19:55875134-55875644	A549	lung:	n/a	n/a
46	RFX5	chr19:55875910-55876036	K562	blood:	n/a	n/a
47	SIN3AK20	chr19:55875267-55875745	A549	lung:	n/a	n/a
48	SIN3AK20	chr19:55875294-55875770	A549	lung:	n/a	n/a
49	TCF12	chr19:55874940-55875784	A549	lung:	n/a	n/a
50	USF1	chr19:55876136-55876548	A549	lung:	n/a	n/a

(count:610 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:55875605-55875655	HUVEC	blood vessel:	n/a
2	chr19:55874586-55874636	PrEC	prostate:	n/a
3	chr19:55874500-55874550	AG10803	skin:	n/a
4	chr19:55874700-55874750	Caco-2	colon:	n/a
5	chr19:55874586-55874636	SK-N-MC	brain:	n/a
6	chr19:55875605-55875655	NH-A	brain:	n/a
7	chr19:55876060-55876110	BJ	skin:	n/a
8	chr19:55873791-55873841	AG09309	skin:	n/a
9	chr19:55874500-55874550	HRCEpiC	kidney:	n/a
10	chr19:55874500-55874550	LNCaP	prostate:	n/a
11	chr19:55876060-55876110	RPTEC	kidney:	n/a
12	chr19:55874335-55874385	IMR90	lung:	fetal
13	chr19:55876060-55876110	PrEC	prostate:	n/a
14	chr19:55874586-55874636	AoSMC	blood vessel:	n/a
15	chr19:55874586-55874636	HNPCEpiC	eye:	n/a
16	chr19:55874500-55874550	AG09319	gingival:	n/a
17	chr19:55873791-55873841	SK-N-SH	brain:	n/a
18	chr19:55876060-55876110	MCF10A-Er-Src	breast:	n/a
19	chr19:55873791-55873841	GM12878	blood:	n/a
20	chr19:55874335-55874385	NB4	blood:	n/a
21	chr19:55874335-55874385	MCF-7	breast:	n/a
22	chr19:55874700-55874750	GM19239	blood:	n/a
23	chr19:55874700-55874750	HCF	heart:	n/a
24	chr19:55874700-55874750	NB4	blood:	n/a
25	chr19:55875605-55875655	HRCEpiC	kidney:	n/a
26	chr19:55874586-55874636	NHBE	bronchial:	n/a
27	chr19:55873791-55873841	AG10803	skin:	n/a
28	chr19:55874700-55874750	MCF10A-Er-Src	breast:	n/a
29	chr19:55873983-55874033	AG04449	skin:	fetal
30	chr19:55874586-55874636	SK-N-SH	brain:	n/a
31	chr19:55877371-55877421	HepG2	liver:	n/a
32	chr19:55873791-55873841	BE2_C	brain:	n/a
33	chr19:55876060-55876110	IMR90	lung:	fetal
34	chr19:55874851-55874901	NHDF-neo	bronchial:	n/a
35	chr19:55874700-55874750	PFSK-1	brain:	n/a
36	chr19:55876060-55876110	U87	brain:	n/a
37	chr19:55874851-55874901	AoSMC	blood vessel:	n/a
38	chr19:55877371-55877421	PFSK-1	brain:	n/a
39	chr19:55874335-55874385	NT2-D1	testis:	n/a
40	chr19:55874700-55874750	HEEpiC	esophagus:	n/a
41	chr19:55874586-55874636	HMEC	breast:	n/a
42	chr19:55875605-55875655	GM12878	blood:	n/a
43	chr19:55874700-55874750	A549	lung:	n/a
44	chr19:55874500-55874550	AG09309	skin:	n/a
45	chr19:55873983-55874033	SK-N-MC	brain:	n/a
46	chr19:55875605-55875655	HMEC	breast:	n/a
47	chr19:55874335-55874385	Hepatocyte	liver:	n/a
48	chr19:55877371-55877421	GM06990	blood:	n/a
49	chr19:55873983-55874033	GM12891	blood:	n/a
50	chr19:55874700-55874750	HL-60	blood:	n/a

(count:18 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:55877367..55879452-chr19:55882812..55884383,2	K562	blood:
2	chr19:55872617..55875125-chr19:55881370..55883672,2	K562	blood:
3	chr19:55874299..55876098-chr19:55878780..55880715,2	K562	blood:
4	chr19:55872735..55877378-chr19:55878459..55880098,5	MCF-7	breast:
5	chr19:55868108..55872228-chr19:55874382..55877630,4	K562	blood:
6	chr19:55872147..55875417-chr19:55876123..55877733,3	K562	blood:
7	chr19:55876201..55879946-chr19:55894605..55900149,8	K562	blood:
8	chr19:55866844..55868519-chr19:55877122..55879184,2	K562	blood:
9	chr19:55861836..55864418-chr19:55872988..55875222,3	K562	blood:
10	chr19:55789877..55791428-chr19:55876107..55878357,2	K562	blood:
11	chr19:55874602..55877064-chr19:55916927..55920725,3	K562	blood:
12	chr19:55868105..55871088-chr19:55873603..55877567,3	MCF-7	breast:
13	chr19:55865433..55867142-chr19:55875019..55877075,2	MCF-7	breast:
14	chr18:68131982..68132686-chr19:55877078..55877580,2	HCT-116	colon:
15	chr19:55851377..55854272-chr19:55873809..55875979,2	MCF-7	breast:
16	chr19:55876167..55879423-chr19:55882046..55885127,4	K562	blood:
17	chr19:55869619..55872464-chr19:55877833..55879873,3	K562	blood:
18	chr19:55806050..55808279-chr19:55877591..55880047,2	K562	blood:

No data

(count:6 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location
1	IL11	hsa-miR-204-5p	chr19:55877002-55877023
2	IL11	hsa-miR-124-3p	chr19:55877224-55877217
3	IL11	hsa-miR-211-5p	chr19:55875919-55875940
4	IL11	hsa-miR-211-5p	chr19:55877002-55877023
5	IL11	hsa-miR-204-5p	chr19:55875919-55875940
6	IL11	hsa-miR-124-3p	chr19:55877218-55877236

Variant related genes	Relation type
ENSG00000267706	TF binding region
FAM71E2	TF binding region
ENSG00000267706	CpG island
FAM71E2	CpG island
ENSG00000267706	chromatin interactions
ENSG00000133247	chromatin interactions
ENSG00000233493	chromatin interactions
ENSG00000180043	chromatin interactions
ENSG00000095752	chromatin interactions
ENSG00000108106	chromatin interactions
ENSG00000108107	chromatin interactions
ENSG00000160471	chromatin interactions
ENSG00000133265	chromatin interactions

Extended variants
information (count: 209 )
Associated
traits (count: 72 )

Variant overlapped rSNPs/rCNVs (count:209 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4252572	chr19:55873726-55873727	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs369950987	chr19:55873757-55873758	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs151037463	chr19:55873768-55873769	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs542560493	chr19:55873769-55873770	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs184852010	chr19:55873791-55873792	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs572710010	chr19:55873811-55873812	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
7	rs146581813	chr19:55873838-55873839	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
8	rs560034885	chr19:55873864-55873865	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
9	rs532223065	chr19:55873892-55873893	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
10	rs551948244	chr19:55873905-55873906	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
11	rs562511069	chr19:55873916-55873917	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs531181821	chr19:55873940-55873941	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
13	rs548095636	chr19:55873953-55873954	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
14	rs568000809	chr19:55873984-55873985	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
15	rs533767318	chr19:55874041-55874042	Bivalent Enhancer Enhancers Genic enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs547566824	chr19:55874113-55874114	Bivalent Enhancer Enhancers Genic enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
17	rs570512508	chr19:55874116-55874117	Bivalent Enhancer Enhancers Genic enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs539926007	chr19:55874127-55874128	Bivalent Enhancer Enhancers Genic enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs556354024	chr19:55874149-55874150	Bivalent Enhancer Enhancers Genic enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs4252571	chr19:55874169-55874170	Bivalent Enhancer Enhancers Genic enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs535831958	chr19:55874175-55874176	Bivalent Enhancer Enhancers Genic enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs11666635	chr19:55874177-55874178	Bivalent Enhancer Enhancers Genic enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs556122628	chr19:55874211-55874212	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
24	rs572770672	chr19:55874228-55874229	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
25	rs541684312	chr19:55874231-55874232	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs558342257	chr19:55874274-55874275	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs187594208	chr19:55874312-55874313	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs545908171	chr19:55874315-55874316	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs562412077	chr19:55874320-55874321	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
30	rs17856934	chr19:55874326-55874327	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
31	rs192777668	chr19:55874338-55874339	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
32	rs369448868	chr19:55874400-55874401	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
33	rs541404466	chr19:55874422-55874423	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
34	rs561694255	chr19:55874459-55874460	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
35	rs370463117	chr19:55874467-55874468	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
36	rs547328253	chr19:55874481-55874482	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
37	rs570647071	chr19:55874519-55874520	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
38	rs532948702	chr19:55874530-55874531	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
39	rs4252570	chr19:55874532-55874533	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs570141073	chr19:55874549-55874550	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
41	rs536384320	chr19:55874550-55874551	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
42	rs142196576	chr19:55874558-55874559	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
43	rs555785672	chr19:55874559-55874560	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
44	rs554348946	chr19:55874570-55874571	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
45	rs189723457	chr19:55874571-55874572	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
46	rs558142671	chr19:55874594-55874595	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
47	rs4252569	chr19:55874619-55874620	Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs375442151	chr19:55874635-55874636	Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
49	rs4252568	chr19:55874642-55874643	Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs555869052	chr19:55874701-55874702	Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:72)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Acute myeloid leukemia	20729466	CNVD
Ovarian cancer	22174824	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Wilms tumour	21544195	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Congenital anomalies of the kidney and urinary tract	18852474	CNVD
Glioblastoma multiforme	17002787	CNVD
Cervical cancer	21062161	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Prostate cancer	16573809	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Lung cancer	18438408	CNVD
Colorectal cancer	16272173	CNVD
Ovarian cancer	21781307	CNVD
Neuroblastoma	20406844	CNVD
Breast cancer	21785460	CNVD
Breast cancer	20459607	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Myelofibrosis	22110671	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Alzheimer''s disease	22166940	CNVD
Heart disease	21282601	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Glioblastoma multiforme	21922591	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	21509527	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:91 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:55866200-55880600	Weak transcription	Right Atrium	heart
2	chr19:55869800-55874000	Weak transcription	Placenta Amnion	Placenta Amnion
3	chr19:55871400-55877000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
4	chr19:55871400-55880200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
5	chr19:55871800-55874200	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
6	chr19:55872000-55874000	Weak transcription	H1 Cell Line	embryonic stem cell
7	chr19:55873400-55879800	Weak transcription	HSMM	muscle
8	chr19:55873600-55873800	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
9	chr19:55873600-55874200	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
10	chr19:55873600-55874400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
11	chr19:55873600-55874600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
12	chr19:55873600-55874600	Bivalent/Poised TSS	Foreskin Melanocyte Primary Cells skin01	Skin
13	chr19:55873600-55875200	Enhancers	Placenta	Placenta
14	chr19:55873600-55876200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
15	chr19:55873800-55874000	Weak transcription	HUES6 Cell Line	embryonic stem cell
16	chr19:55873800-55874000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
17	chr19:55874000-55874200	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
18	chr19:55874000-55874200	Bivalent/Poised TSS	HepG2	liver
19	chr19:55874000-55874400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
20	chr19:55874000-55874400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
21	chr19:55874000-55874400	Enhancers	Placenta Amnion	Placenta Amnion
22	chr19:55874000-55874600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
23	chr19:55874000-55874600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
24	chr19:55874000-55874600	Bivalent Enhancer	Fetal Stomach	stomach
25	chr19:55874000-55874800	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
26	chr19:55874000-55874800	Enhancers	H1 Cell Line	embryonic stem cell
27	chr19:55874000-55874800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
28	chr19:55874000-55874800	Enhancers	HUES6 Cell Line	embryonic stem cell
29	chr19:55874200-55874400	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
30	chr19:55874200-55874400	Flanking Bivalent TSS/Enh	HepG2	liver
31	chr19:55874200-55874800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
32	chr19:55874200-55874800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
33	chr19:55874200-55874800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
34	chr19:55874200-55874800	Enhancers	iPS-15b Cell Line	embryonic stem cell
35	chr19:55874200-55874800	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
36	chr19:55874200-55874800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
37	chr19:55874200-55875000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
38	chr19:55874200-55875200	Enhancers	A549	lung
39	chr19:55874400-55874600	Bivalent Enhancer	HepG2	liver
40	chr19:55874400-55874800	Enhancers	HUES48 Cell Line	embryonic stem cell
41	chr19:55874400-55874800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
42	chr19:55874400-55875800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
43	chr19:55874600-55875200	Enhancers	HepG2	liver
44	chr19:55874600-55876000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
45	chr19:55874600-55879600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
46	chr19:55874800-55875800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
47	chr19:55874800-55875800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
48	chr19:55874800-55876600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
49	chr19:55874800-55877000	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
50	chr19:55874800-55877400	Weak transcription	HUES6 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links